Sandip Kapadia - Net Worth and Insider Trading

Sandip Kapadia Net Worth

The estimated net worth of Sandip Kapadia is at least $451,516 dollars as of 2024-07-15. Sandip Kapadia is the CFO and Treasurer of Intercept Pharmaceuticals Inc and owns about 23,764 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $451,516. Sandip Kapadia is also the Director of Passage Bio Inc and owns about 0 shares of Passage Bio Inc (PASG) stock worth over $0. Details can be seen in Sandip Kapadia's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sandip Kapadia has not made any transactions after 2022-12-01 and currently still holds the listed stock(s).

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sandip Kapadia

To

Sandip Kapadia Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sandip Kapadia owns 3 companies in total, including Intercept Pharmaceuticals Inc (ICPT) , Passage Bio Inc (PASG) , and Harmony Biosciences Holdings Inc (HRMY) .

Click here to see the complete history of Sandip Kapadia’s form 4 insider trades.

Insider Ownership Summary of Sandip Kapadia

Ticker Comapny Transaction Date Type of Owner
ICPT Intercept Pharmaceuticals Inc 2021-01-05 CFO and Treasurer
PASG Passage Bio Inc 2022-12-01 director
HRMY Harmony Biosciences Holdings Inc 2021-03-29 Chief Financial Officer

Sandip Kapadia Latest Holdings Summary

Sandip Kapadia currently owns a total of 2 stocks. Among these stocks, Sandip Kapadia owns 23,764 shares of Intercept Pharmaceuticals Inc (ICPT) as of January 5, 2021, with a value of $451,516 and a weighting of 100%. Sandip Kapadia also owns 0 shares of Passage Bio Inc (PASG) as of December 1, 2022, with a value of $0 and a weighting of 0%.

Latest Holdings of Sandip Kapadia

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ICPT Intercept Pharmaceuticals Inc 2021-01-05 23,764 19.00 451,516
PASG Passage Bio Inc 2022-12-01 0 0.93 0

Holding Weightings of Sandip Kapadia


Sandip Kapadia Form 4 Trading Tracker

According to the SEC Form 4 filings, Sandip Kapadia has made a total of 2 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 2,193 shares on January 5, 2021, which brought Sandip Kapadia around $53,663.

According to the SEC Form 4 filings, Sandip Kapadia has made a total of 2 transactions in Passage Bio Inc (PASG) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Passage Bio Inc is the sale of 5,000 shares on December 1, 2022, which brought Sandip Kapadia around $5,950.

Insider Trading History of Sandip Kapadia

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sandip Kapadia Trading Performance

GuruFocus tracks the stock performance after each of Sandip Kapadia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandip Kapadia is 22.05%. GuruFocus also compares Sandip Kapadia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandip Kapadia within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sandip Kapadia's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sandip Kapadia

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -27.05 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.91 LIMIT LIMIT LIMIT LIMIT LIMIT

Sandip Kapadia Ownership Network

Ownership Network List of Sandip Kapadia

No Data

Ownership Network Relation of Sandip Kapadia

Insider Network Chart

Sandip Kapadia Owned Company Details

What does Intercept Pharmaceuticals Inc do?

Who are the key executives at Intercept Pharmaceuticals Inc?

Sandip Kapadia is the CFO and Treasurer of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

Sandip Kapadia Mailing Address

Above is the net worth, insider trading, and ownership report for Sandip Kapadia. You might contact Sandip Kapadia via mailing address: 450 West 15 Street, Suite 505, New York Ny 10011.

Discussions on Sandip Kapadia

No discussions yet.